Book a Meeting

BetterBet™ Anti-HER2, a Half-Life Extended Antibody (CAT#: AES-0622-ZP1075) Datasheet

Target
HER2
Description
Creative Biolabs enhances the binding ability of the antibody to FcRn by modifying the Fc of the antibody, thereby increasing the half-life of the antibody. The half-life of traditional antibodies is about 3 weeks, and the half-life of the modified antibodies can be increased to more than 50 days in the upper part, which theoretically can greatly reduce the frequency of dosing.
Applications
Increase the half-life of antibodies
Technology
Fc engineering technology

Cooperation Seeking

ERBB2
Official Name
erb-b2 receptor tyrosine kinase 2
Background
NEU; NGL; HER2; TKR1; CD340; HER-2; MLN 19; HER-2/neu

The Fc of the antibody is engineered to enhance the binding ability of the antibody to FcRn, thereby increasing the half-life of the antibody

Related Products

Non-Fucosylated Anti-Human HER2 (Ado-trastuzumab emtansine) Therapeutic Antibody, an ADCC-Enhanced Biobetter (CAT#: BioBet-1774ZP)
Non-Fucosylated Anti-Human HER2 (MBS301) Therapeutic Antibody, an ADCC-Enhanced Biobetter (CAT#: BioBet-1705ZP)
BetterBet™ Anti-HER2 Recycling Antibody (CAT#: AES-0622-ZP91)
BetterBet™ Anti-HER2, a FcγRIIB Binding Enhanced Antibody (CAT#: AES-0622-ZP419)
BetterBet™ Anti-HER2 On-Target Antibody (CAT#: AES-0622-ZP747)
ADCC-Enhanced Anti-Human HER2 ([vic-]trastuzumab) Antibody, a biobetter (CAT#: BioBet-CB-033LX)
Non-fucosylated Anti-Human HER2 Therapeutic Antibody, an ADCC-Enhanced Biobetter [Lot: CB20-PZ07] (CAT#: BioBet-007ZP)
Highly Galactosylated Anti-HER2 Trastuzumab, a Biobetter Antibody (CAT#: BioBet-GA-002ZP)

All products and services are for Research Use Only. Do Not use in humans.

ONLINE INQUIRY

Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.

  • *
  • *
  • *
USA

UK

Germany